Yoon Hang Kim MD

Board certified preventive medicine physician. University of Arizona fellowship grad. 20+ years prescribing LDN for chronic pain, autoimmune conditions & complex cases. Author. International speaker. Helping patients find answers.

Rapamycin (found in Rapa Nui or Easter Island) Beyond Transplant Medicine: Longevity, Mast Cell Activation Syndrome, and Autoimmune Disease Through a Functional Medicine Lens

rapamycine

Rapamycin (found in Rapa Nui or Easter Island) Beyond Transplant Medicine: Longevity, Mast Cell Activation Syndrome, and Autoimmune Disease Through a Functional Medicine Lens

Yoon Hang "John" Kim, MD, MPH Board-Certified in Preventive Medicine | Integrative & Functional Medicine Abstract Rapamycin (sirolimus), an mTOR inhibitor originally developed for transplant immunosuppression, has emerged as the most extensively studied pharmacologic candidate for mammalian lifespan extension and is now being explored for immune dysregulation conditions

By Yoon Hang Kim MD
A CLINICAL DISCUSSION: Hormone Replacement Therapy After Breast Cancer A Multidisciplinary Case Discussion

breast cancer

A CLINICAL DISCUSSION: Hormone Replacement Therapy After Breast Cancer A Multidisciplinary Case Discussion

BY Yoon Hang Kim, MD, MPH ◆   ◆   ◆ When Standard Guidance Meets Unusual Biology HYPOTHETICAL CASE DISCUSSION For educational and clinical reasoning purposes only EXECUTIVE SUMMARY The Question at the Center of This Case A postmenopausal woman with a complex breast cancer history sits at the intersection of three competing risks: progressive

By Yoon Hang Kim MD

Mast Cell Activation Syndrome Versus Mastocytosis - Distinguishing Activation from Proliferation in Clinical Practice

Yoon Hang Kim, MD, MPH Board-Certified in Preventive Medicine | Integrative & Functional Medicine Physician Important: This article is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Mast cell disorders require individualized evaluation by qualified specialists. If you experience symptoms suggestive of anaphylaxis — airway compromise,

By Yoon Hang Kim MD

Low-Dose Naltrexone Is Not a Rescue Medication: Setting Realistic Expectations for a Regulatory and Modulatory Therapy

Yoon Hang Kim, MD, MPH Board-Certified in Preventive Medicine | Integrative & Functional Medicine Physician Introduction Low-dose naltrexone (LDN) has gained increasing recognition as a valuable tool in integrative and functional medicine, particularly for chronic inflammatory, autoimmune, and neuroimmune conditions. However, as clinical interest in LDN has grown, so

By Yoon Hang Kim MD